EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis

Bianqiao Cheng iD, Dandan Wu, Ming Zhang, Shiming Chen, Xunyuan Wu, Jingjing Zhong, Meimei Wu, Miaomiao Huo

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Bianqiao Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fuzhou Second Hospital, Fujian, China. Hauptthemen laut MEDLINE: Hepatitis B e Antigens, Hepatitis B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation Project of Fujian Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to investigate the role of immunocompetence in chronic hepatitis B (CHB) patients with normal alanine transaminase (ALT) levels and negative hepatitis B e antigen (HBeAg) in the risk assessments of the progression of liver fibrosis.

Methods

We collected the clinical data of 57 patients with CHB, with normal ALT levels and negative HBeAg from December 2020 to December 2022. With hepatitis B virus (HBV) DNA > 20 IU/mL and ALT ≤ 40 U/L, these patients had never undergone antiviral therapy. The levels of CD4 + , CD4 + CD25 + , CD8 + , and CD4 + CD25 + CD127 LOW regulatory T cells (Tregs) in the patients were detected using flow cytometry; the liver stiffness measurement (LSM) values of the patients were detected using Fibroscan.

Results

There was a statistically significant difference between the levels of fibrosis‐4 (FIB‐4) and hepatitis B surface antigen (HBsAg) when the cutoff point was HBsAg ≥ 1500 ( p < .001). FIB‐4 was negatively correlated with HBsAg ( R = −0.291, p = .028) and positively correlated with age ( R = 0.787, p < .001). LSM was negatively correlated with Treg but this correlation was not statistically significant ( p > .05). Findings based on the analysis using logistic regression were as follows: (i) age was the independent risk factor when FIB‐4 was used as the indicator for assessing liver fibrosis; (ii) Treg was the independent risk factor when LSM was used as the indicator for assessing liver fibrosis. When Treg was used to predict liver fibrosis, the cutoff value, diagnostic efficacy, area under the receiver operating characteristic (ROC) curve, and p value of the ROC curve were 6.875, 0.641, 0.84, and .027, respectively.

Conclusion

Age and Treg are independent risk factors for progressive liver fibrosis. The cutoff value of Treg > 6.81 indicates the need for timely antiviral treatment and can serve as an indicator for evaluating liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B e AntigensHepatitis BHumansAlanine TransaminaseHepatitis B Surface AntigensLiver CirrhosisHepatitis, ChronicImmunocompetence

Stichwörter der Autor:innen

ALTCHBHBeAg-negativeTregprogressive liver fibrosis

Substanzen

Hepatitis B e AntigensAlanine TransaminaseHepatitis B Surface Antigens

Autor:innen und Institutionen

  • Department of Gastroenterology, Fuzhou Second Hospital, Fujian, China.
  • Department of Clinical Medicine, Fujian Medical University, Fujian, China.
  • Department of Infection Management, Fuzhou Second Hospital, Fujian, China.

ORCID-Profile: Bianqiao Cheng

Förderung

  • Natural Science Foundation Project of Fujian Provincial Science and Technology Department

Zitieren

APA

Cheng, B., Wu, D., Zhang, M., Chen, S., Wu, X., Zhong, J., Wu, M., & Huo, M. (2024). High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1134

Vancouver

Cheng B, Wu D, Zhang M, Chen S, Wu X, Zhong J, et al. High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1134

BibTeX
@article{Cheng2024,
  author = {Cheng, Bianqiao and Wu, Dandan and Zhang, Ming and Chen, Shiming and Wu, Xunyuan and Zhong, Jingjing and Wu, Meimei and Huo, Miaomiao},
  title = {High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1134}
}
Kostenlos starten →